Stage IIIB Skin Melanoma Completed Phase 0 Trials for Hyaluronic acid (DB08818)

Indication	Status	Phase
DBCOND0029534 (Stage IIIB Skin Melanoma)	Completed	0

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02320305	MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery	Treatment	Aloe vera leaf (DB13906) Coconut oil (DB14322) G100 (DB17244) Hyaluronic acid (DB08818) Melanoma antigen recognized by T-cells 1 (DB15081) Propylene glycol (DB01839) Rosemary (DB14272)